menu
Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical :Roots:
Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical :Roots:
Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical

Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical

Giventhe complex R&D protocols and the increasing demand for clinical evidenceof therapeutic benefit, there seems to be a lucrative opportunity for contractresearch providers engaged in the medical devices’ domain. In fact, since 2000,150 new CROs have been established that offer a variety of cost-efficientservices and solutions to medical device developers.

 

To order this 400+ page report, which features 240+figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

 

The USD 15.7 billion (by 2030) financialopportunity within the antibody contract manufacturing market has been analyzedacross the following segments:

§ Phase of Development

§ Clinical

§ Preclinical

 

§ Types of PreclinicalServices Offered

§ Biocompatibilitytesting

§ Sterility andmicrobiology testing

§ Material characterizationand analytical services

§ Others

 

§ Types of ClinicalServices Offered

§ Clinical trialmanagement

§ Data management

§ Regulatory affairsmanagement

§ Consulting

§ Others

 

§ Device Class

§ Class I medicaldevices

§ Class II medicaldevices

§ Class III medicaldevices

 

§ Target TherapeuticArea

§ CNS disorders

§ Cardiovasculardisorders

§ Oncological disorders

§ Bone disorders

§ Respiratory disorders

§ Pain managementdisorders

§ Ophthalmic disorders

§ Psychologicaldisorders

§ Metabolic disorders

§ Others

 

§ Key GeographicalRegions

§ North America

§ Europe

§ Asia-Pacific

§ Rest of the World

 

TheMedical Device CRO Market (2nd Edition), 2020-2030”. report featuresthe following companies, which we identified to be key players in this domain:

§ Avania (formerlyknown as Factory CRO)

§ Charles RiverLaboratories

§ Clinlogix

§ CROMSOURCE

§ CSSi LifeSciences™

§ Eurofins Medical DeviceTesting

§ genae

§ IMARC Research

§ IQVIA

§ Medpace

§ NAMSA

§ Qserve Group

§ Regulatory andClinical Research Institute (now a part of Covance)

§ WuXi AppTec

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape

5. Regulatory and Reimbursement Landscape for MedicalDevices

6. Company Profiles

7. Medical Device Developer and CRORelationships: Key Value Drivers and Performance Indicators 

8. Competitive Benchmarking

9. Brand Positioning of Key IndustryPlayers

10. Clinical Trial Analysis

11. Mergers and Acquisitions

12. Survey Insights

13. Market Sizing and Forecast

14. Case Study: Impact of Coronavirus Outbreak

 

15. SWOT Analysis

 

16. Future Trends and Opportunities

 

17. Interview Transcripts

 

18. Appendix 1: Tabulated Data

 

19. Appendix 2: List of Companies andOrganizations

 

Topurchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com